top of page
Home: Who We Are

HEAD & NECK CANCER INTERNATIONAL GROUP

Welcome.

The Head and Neck Cancer International Group aims to promote and conduct high quality clinical trials in order to improve outcomes in patients with head and neck cancers. We achieve this through international collaboration, a strong sense of common purpose, shared expertise, and mutual respect among members.

Research Proposals

Research Proposals are invited via the application portal.

The online application form may be accessed here.

Applications will be initially assessed by the New Project Review Group, which meets monthly. If deemed suitable, the application will then be forwarded to the appropriate Sub-committee (e.g. Clinical Studies, Translational Studies, Young Investigator, Guidelines & Protocols) who have established protocols which will enable a more thorough examination of the proposal.

The applicant will be kept informed of the progress of the application.

HNCIG meeting image.png
Home: List

AIMS OF HNCIG

Promote international collaboration
Promote clinical research
Perform studies in rare tumors
Harmonize the technical aspects of radiation delivery
Develop a credentialing process for novel radiation and surgical approaches
Promote translational research
Stimulate evidence-based medicine
Support educational activities
Multinational, real-world data and AI studies
Harmonization of head and neck cancer research  protocols, methodologies, and endpoints

Dazzling Light

SCIENTIFIC COMMITTEE

Open Laptop

GUIDELINES & PROTOCOLS COMMITTEE

People Walking

YOUNG INVESTIGATOR COMMITTEE

Two Men Shaking Hands

PARTNERSHIPS COMMITTEE

Elegant Abstract Background

DATABASE COMMITTEE

2021-06-28 09_30_07-Head & Neck logo High Res (1).pdf.png

Our logo was designed by Steve Smith, graphic designer from Leicestershire, England. Since studying graphic design at York University, he has spent the last 30 years running his own small company. He was inspired to design our logo after reading about our research and efforts. Thank you, Steve.

Merck has supported HNCIG with unrestricted grants for medical education and treatment guidelines.
Subscribe to the HNCIG Newsletter

Thanks for subscribing!

bottom of page